Literature DB >> 3539572

Tamoxifen and mastalgia. An emerging indication.

I S Fentiman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3539572     DOI： 10.2165/00003495-198632060-00001

Source DB:  PubMed          Journal:  Drugs        ISSN： 0012-6667            Impact factor:   9.546


× No keyword cloud information.
  17 in total

1.  A suggested classification of breast pain.

Authors:  H M Bishop; R W Blamey
Journal:  Postgrad Med J       Date:  1979       Impact factor: 2.401

2.  3H-oestradiol uptake in vivo by human uterine endometrium: effect of tamoxifen (I.C.I. 46,474).

Authors:  C B Lunan; B Green
Journal:  Clin Endocrinol (Oxf)       Date:  1974-10       Impact factor: 3.478

Review 3.  Postcoital contraception.

Authors:  C W Emmens
Journal:  Br Med Bull       Date:  1970-01       Impact factor: 4.291

4.  Prophylactic tamoxifen.

Authors:  V C Jordan; N F Fritz; M van Beurden
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321

5.  Double-blind controlled trial of tamoxifen therapy for mastalgia.

Authors:  I S Fentiman; M Caleffi; K Brame; M A Chaudary; J L Hayward
Journal:  Lancet       Date:  1986-02-08       Impact factor: 79.321

6.  The effect of tamoxifen on bone mineral content in premenopausal women with breast cancer.

Authors:  A Gotfredsen; C Christiansen; T Palshof
Journal:  Cancer       Date:  1984-02-15       Impact factor: 6.860

7.  Primary treatment of breast cancer in elderly women with Tamoxifen.

Authors:  J W Bradbeer; J Kyngdon
Journal:  Clin Oncol       Date:  1983-03

8.  Venous thrombosis as a side effect of tamoxifen treatment.

Authors:  A Lipton; H A Harvey; R W Hamilton
Journal:  Cancer Treat Rep       Date:  1984-06

9.  Beneficial effect of adjuvant tamoxifen therapy in primary breast cancer patients with high oestrogen receptor values.

Authors:  C Rose; S M Thorpe; K W Andersen; B V Pedersen; H T Mouridsen; M Blichert-Toft; B B Rasmussen
Journal:  Lancet       Date:  1985-01-05       Impact factor: 79.321

10.  Clinical syndromes of mastalgia.

Authors:  P E Preece; R E Mansel; P M Bolton; L M Hughes; M Baum; I H Gravelle
Journal:  Lancet       Date:  1976-09-25       Impact factor: 79.321
View more
  2 in total

Review 1.  Comparative tolerability of first-generation selective estrogen receptor modulators in breast cancer treatment and prevention.

Authors:  M G Curtis
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  LHRH analogue for treatment of recurrent and refractory mastalgia.

Authors:  H Hamed; M Caleffi; M A Chaudary; I S Fentiman
Journal:  Ann R Coll Surg Engl       Date:  1990-07       Impact factor: 1.891
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.